Clients in the Media Found 3 Results November 3, 2025 | Abivax BIO-Europe 2025: Abivax CEO Marc de Garidel discusses physician and payor feedback after obefazimod’s phase 3 UC induction readouts, and next steps regarding maintenance and Crohn’s BiotechTV October 6, 2025 | Abivax Top 1% Biotech Abivax Surges On ‘Compelling’ Results In A Highly Watched Disease Investor's Business Daily October 6, 2025 | Abivax Abivax releases more data from major Phase 3 wins in ulcerative colitis Endpoints